Very low birth weight and respiratory outcome: association between airway inflammation and hyperresponsiveness

L Pekka Malmberg1, Anna S Pelkonen, Kristiina Malmström

  • 1Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland. pekka.malmberg@hus.fi

Insights

Airway hyperresponsiveness (AHR) in very low birth weight (VLBW) children is linked to fractional exhaled nitric oxide (FeNO), but only in those with atopy. This association involves bronchial nitric oxide flux, not alveolar concentration.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Neonatology

Background:

  • Respiratory outcomes in preterm infants have evolved.
  • The relationship between childhood airway hyperresponsiveness (AHR) and airway inflammation remains unclear.

Purpose of the Study:

  • To investigate the association between AHR and fractional exhaled nitric oxide (FeNO), including alveolar nitric oxide concentration, in school-age children with very low birth weight (VLBW).

Main Methods:

  • Compared 29 VLBW children, 33 with early wheeze history, and 60 controls.
  • Assessed FeNO, histamine bronchial challenge, and atopy via skin prick tests.

Main Results:

  • VLBW children showed increased AHR but similar FeNO levels to controls.
  • AHR correlated with FeNO in VLBW and early wheeze groups, specifically in atopic individuals.
  • Bronchial nitric oxide flux, not alveolar concentration, associated with AHR in VLBW and early wheeze groups.

Conclusions:

  • In VLBW children, AHR is linked to FeNO, but only in atopic subjects.
  • The association between AHR and FeNO is driven by bronchial flux, similar to early wheeze patients.
  • Atopic inflammation, rather than prematurity-related inflammation, likely modifies AHR in VLBW children.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.